Sector Investors News and Insights

Nephros (NASDAQ:NEPH) is given a Speculative Buy Rating by Benchmark.

Benchmark reissued their speculative buy rating on shares of Nephros (NASDAQ:NEPH – Free Report) in a report published on Wednesday, Benzinga reports. The firm currently has a $5.00 target price on…

Read More: https://www.tickerreport.com/banking-finance/12005899/nephros-nasdaqneph-receives-speculative-buy-rating-from-benchmark.html

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com